Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation

NCT02859142 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT02859142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02859142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
Lead sponsor
University of Chicago
Phase
Phase 4
Overall status
Completed
Start date
March 29, 2018
Completion date
October 15, 2020
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, smoking cessation